Tag: PLoS

FDA approval of drugs and transparency in clinical trial results

Note: The reason that I am posting today rather than my usual Monday slot is because the article I discuss here was embargoed until last night. Consequently, I asked Harriet if she would trade days with me this week, and she was kind enough to do so. One thing that science relies on almost absolutely is transparency. Because one of the most...

/ September 23, 2008